Antifungal susceptibility testing and determination of local epidemiological cut-off values for Candida species isolated from women with vulvovaginal candidiasis
Microbiology Spectrum · 04.03.2025 · 13 (3)
DOI: 10.1128/spectrum.02488-24 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microbiology Spectrum, erschienen am 04.03.2025. Verfasst von Vasiliki Kroustali und 5 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Microbiology Laboratory, "Attikon" University General Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Gree…. Hauptthemen laut MEDLINE: Candidiasis, Vulvovaginal, Antifungal Agents, Candida. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 93 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The lack of clinical breakpoints and epidemiological cut-off values (ECOFFs) for antifungals prescribed for vulvovaginal candidiasis (VVC) make interpretation of antifungal susceptibility data difficult. This leads to empirical prescribing, poor clinical management and emergence of resistance. The in vitro susceptibilities of 152 Candida albicans , 105 Candida parapsilosis , 31 Nakaseomyces glabratus, and 8 Pichia kudriavzevii VVC isolates against eight antifungals, were determined according to the European Committee on Antimicrobial Susceptibility Testing (EUCAST) E.Def 7.4. The minimum inhibitory concentration (MIC) distributions were analyzed and local ECOFFs were determined visually and statistically. The in vitro activity of azoles was correlated with fluconazole susceptibility and clinical data were evaluated. The MICs of various azoles showed a significant correlation with the MICs of fluconazole and fluconazole non-wild type (WT) isolates had significantly higher MICs for other azoles. The estimated local ECOFFs for C. albicans were 0.016 mg/L (ketoconazole, clotrimazole), 0.06 mg/L (miconazole, econazole, itraconazole), 1 mg/L (fenticonazole), and 3,200 mg/L (boric acid). For C. parapsilosis , local ECOFFs were 0.06 mg/L (ketoconazole, clotrimazole, itraconazole), 1 mg/L (miconazole, econazole), 2 mg/L (fenticonazole), and 3,200 mg/L (boric acid). For N. glabratus , they were 1 mg/L (ketoconazole, clotrimazole, miconazole, itraconazole), 2 mg/L (econazole, fenticonazole), and 12,800 mg/L (boric acid). Non-WT isolates were detected for azoles in N. glabratus (10%–35%), C. albicans (5%–16%), and C. parapsilosis (≤ 3%). All isolates were WT for boric acid. Local ECOFFs were established for three major Candida species causing VVC, guiding the identification of non-WT isolates potentially associated with treatment failure. IMPORTANCE The interpretation of in vitro susceptibility data of Candida isolates from women with vulvovaginal candidiasis (VVC) is challenging due to the lack of clinical breakpoints (CBPs) and epidemiological cut-off values (ECOFFs) for drugs used in VVC. In the present study, local ECOFFs were established for three major Candida species causing VVC, guiding the identification of non-wild type isolates potentially associated with treatment failure. This paper provides the framework for developing ECOFFs and ultimately CBPs that would help guide antifungal therapy of VVC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Clinical Microbiology Laboratory, "Attikon" University General Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
- Molecular Microbiology and Immunology Laboratory, Department of Biomedical Sciences, University of West Attica, Athens, Greece.
- "MycoLab", Diagnostic Laboratory of Sexually Transmitted Diseases, Specific Infectious Diseases, Fungal, Microbiological and Cytologic Examinations, Athens, Greece.
- Department of Clinical Microbiology, General Hospital "G. Gennimatas", Athens, Greece.
ORCID-Profile: Vasiliki Kroustali, Maria Siopi, Joseph Meletiadis
Zitieren
APA
Kroustali, V., Kanioura, L., Resoulai, E., Siopi, M., Antonopoulou, S., & Meletiadis, J. (2025). Antifungal susceptibility testing and determination of local epidemiological cut-off values for Candida species isolated from women with vulvovaginal candidiasis. Microbiology Spectrum, 13(3). https://doi.org/10.1128/spectrum.02488-24
Vancouver
Kroustali V, Kanioura L, Resoulai E, Siopi M, Antonopoulou S, Meletiadis J. Antifungal susceptibility testing and determination of local epidemiological cut-off values for Candida species isolated from women with vulvovaginal candidiasis. Microbiology Spectrum. 2025;13(3). doi:10.1128/spectrum.02488-24
BibTeX
@article{Kroustali2025,
author = {Kroustali, Vasiliki and Kanioura, Lamprini and Resoulai, Esmeralda and Siopi, Maria and Antonopoulou, Stavroula and Meletiadis, Joseph},
title = {Antifungal susceptibility testing and determination of local epidemiological cut-off values for Candida species isolated from women with vulvovaginal candidiasis},
journal = {Microbiology Spectrum},
year = {2025},
volume = {13},
number = {3},
doi = {10.1128/spectrum.02488-24}
}
EUVIMED